Biotech
and Pharma
The Biotech & Pharma committee actively supports scientific breakthroughs that solve the world’s most complex biological and health challenges. It focusses on deep innovation across drug development, molecular biology, and advanced medical therapies; targeting innovations in bio-medicine, advanced materials, and environmental informatics aimed at disease treatment, enhanced diagnostics, and life-science engineering.
The committee is strategically founded on a network of highly engaged exited entrepreneurs, leaders from Big Pharma, major life science VC funds, and healthcare professionals.
This collective expertise is uniquely positioned and poised to help you commercialise your technology and profoundly improve patients' lives.
Kia ora, nau mai haere mai ki Biotech & Pharma
We love supporting projects that push the boundaries of science and make a real difference for patients. There’s something inspiring about helping brilliant teams turn discovery into impact. When you present to our Biotech & Pharma Committee, you’re joining a network of people who genuinely want to see you succeed: experienced pharma leaders, exited founders, and active investors who can open doors, share hard-won insights, and accelerate your path to market.
Julia Chambers
Biotech & Pharma Committee Chair
Independent Biotech Consultant & Director
Core
Biotech & Pharma
Committee Members